Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-01-05 @ 5:28 PM
Study NCT ID:
NCT00670358
Status:
COMPLETED
Last Update Posted:
2025-01-10
First Post:
2008-04-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-04
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-30
First Submit QC Date:
None
Study First Post Date:
2008-05-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-09-15
Results First Submit QC Date:
None
Results First Post Date:
2022-11-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-26
Last Update Post Date:
2025-01-10
Last Update Post Date Type:
ACTUAL